News and analysis of Biotech stocks. No buy or sell recommendations.

Visit SeekingAlpha Biotech Stocks

SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial

Posted on August 29, 2008

Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility. Adefovir dipivoxil, the drug newly approved for marketing, is aimed at hepatitis B. It is currently available from more than 10 China pharmaceutical companies, though most of them produce the compound as tablets. SL Pharma will market it as a capsule, the third company in China to have permission to make the drug in this form. ...

Original article link


clinical trial , pharma